PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
Europe • Euronext Milan • BIT:PHN • IT0005274094
63.1 EUR
+0.4 (+0.64%)
Last: Jan 30, 2026, 07:00 PM
Taking everything into account, PHN scores 7 out of 10 in our fundamental rating. PHN was compared to 13 industry peers in the Personal Care Products industry. PHN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, PHN is valued expensive at the moment. These ratings would make PHN suitable for quality investing!
1. Profitability
1.1 Basic Checks
- In the past year PHN was profitable.
- In the past year PHN had a positive cash flow from operations.
- PHN had positive earnings in each of the past 5 years.
- PHN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 20.17%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 36.55%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 25.72%, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for PHN is significantly above the industry average of 11.91%.
- The 3 year average ROIC (17.21%) for PHN is below the current ROIC(25.72%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.17% | ||
| ROE | 36.55% | ||
| ROIC | 25.72% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
- With a decent Profit Margin value of 13.39%, PHN is doing good in the industry, outperforming 76.92% of the companies in the same industry.
- In the last couple of years the Profit Margin of PHN has declined.
- PHN's Operating Margin of 21.79% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
- PHN's Operating Margin has been stable in the last couple of years.
- PHN has a better Gross Margin (97.13%) than 100.00% of its industry peers.
- PHN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.79% | ||
| PM (TTM) | 13.39% | ||
| GM | 97.13% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
- PHN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for PHN remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, PHN has less shares outstanding
- The debt/assets ratio for PHN has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 10.57 indicates that PHN is not in any danger for bankruptcy at the moment.
- The Altman-Z score of PHN (10.57) is better than 100.00% of its industry peers.
- PHN has a debt to FCF ratio of 2.01. This is a good value and a sign of high solvency as PHN would need 2.01 years to pay back of all of its debts.
- PHN has a Debt to FCF ratio of 2.01. This is in the better half of the industry: PHN outperforms 69.23% of its industry peers.
- A Debt/Equity ratio of 0.24 indicates that PHN is not too dependend on debt financing.
- PHN has a Debt to Equity ratio of 0.24. This is in the better half of the industry: PHN outperforms 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | 2.01 | ||
| Altman-Z | 10.57 |
ROIC/WACC3.23
WACC7.97%
2.3 Liquidity
- PHN has a Current Ratio of 2.19. This indicates that PHN is financially healthy and has no problem in meeting its short term obligations.
- PHN has a better Current ratio (2.19) than 92.31% of its industry peers.
- PHN has a Quick Ratio of 1.86. This is a normal value and indicates that PHN is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.86, PHN belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.19 | ||
| Quick Ratio | 1.86 |
3. Growth
3.1 Past
- PHN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.84%, which is quite good.
- PHN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.63% yearly.
- Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 14.35% in the last year.
- PHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.59% yearly.
EPS 1Y (TTM)12.84%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%13.11%
Revenue 1Y (TTM)14.35%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%19.45%
3.2 Future
- PHN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.13% yearly.
- The Revenue is expected to grow by 13.74% on average over the next years. This is quite good.
EPS Next Y6.25%
EPS Next 2Y13.31%
EPS Next 3Y15.13%
EPS Next 5YN/A
Revenue Next Year14.8%
Revenue Next 2Y14.39%
Revenue Next 3Y14.28%
Revenue Next 5Y13.74%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 25.14, PHN can be considered very expensive at the moment.
- 61.54% of the companies in the same industry are more expensive than PHN, based on the Price/Earnings ratio.
- PHN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.30, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 25.84 indicates a quite expensive valuation of PHN.
- PHN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. PHN is more expensive than 61.54% of the companies in the same industry.
- PHN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 25.57.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.14 | ||
| Fwd PE | 25.84 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, PHN is valued a bit more expensive than 69.23% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHN indicates a slightly more expensive valuation: PHN is more expensive than 76.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 58.6 | ||
| EV/EBITDA | 13.96 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- PHN has an outstanding profitability rating, which may justify a higher PE ratio.
- PHN's earnings are expected to grow with 15.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.02
PEG (5Y)1.72
EPS Next 2Y13.31%
EPS Next 3Y15.13%
5. Dividend
5.1 Amount
- PHN has a Yearly Dividend Yield of 1.52%.
- PHN's Dividend Yield is slightly below the industry average, which is at 2.23.
- PHN's Dividend Yield is comparable with the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.52% |
5.2 History
- On average, the dividend of PHN grows each year by 11.21%, which is quite nice.
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 39.70% of the earnings are spent on dividend by PHN. This is a low number and sustainable payout ratio.
- The dividend of PHN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP39.7%
EPS Next 2Y13.31%
EPS Next 3Y15.13%
PHARMANUTRA SPA / PHN.MI FAQ
What is the fundamental rating for PHN stock?
ChartMill assigns a fundamental rating of 7 / 10 to PHN.MI.
Can you provide the valuation status for PHARMANUTRA SPA?
ChartMill assigns a valuation rating of 2 / 10 to PHARMANUTRA SPA (PHN.MI). This can be considered as Overvalued.
What is the profitability of PHN stock?
PHARMANUTRA SPA (PHN.MI) has a profitability rating of 8 / 10.
How financially healthy is PHARMANUTRA SPA?
The financial health rating of PHARMANUTRA SPA (PHN.MI) is 8 / 10.
Is the dividend of PHARMANUTRA SPA sustainable?
The dividend rating of PHARMANUTRA SPA (PHN.MI) is 5 / 10 and the dividend payout ratio is 39.7%.